AB
ATRA icon

Amalgamated Bank’s Atara Biotherapeutics ATRA Stock Holding History

Amalgamated Bank’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-129
Closed -$2K – 3014
2024
Q1 		$2K Sell
129
-244
-65% -$4.33K ﹤0.01% 2868
2023
Q4 		$5K Sell
373
-39
-9% -$909 ﹤0.01% 2937
2023
Q3 		$15K Hold
412
– – ﹤0.01% 2771
2023
Q2 		$17K Buy
412
+4
+1% +$226 ﹤0.01% 2807
2023
Q1 		$30K Sell
408
-70
-15% -$6.79K ﹤0.01% 2497
2022
Q4 		$39K Hold
478
– – ﹤0.01% 2529
2022
Q3 		$45K Buy
478
+1
+0.2% +$112 ﹤0.01% 2503
2022
Q2 		$93K Buy
477
+45
+10% +$7.35K ﹤0.01% 2190
2022
Q1 		$100K Sell
432
-23
-5% -$7.32K ﹤0.01% 2193
2021
Q4 		$179K Buy
455
+9
+2% +$3.79K ﹤0.01% 1989
2021
Q3 		$200K Sell
446
-32
-7% -$11.5K ﹤0.01% 1990
2021
Q2 		$186K Buy
478
+71
+17% +$25.3K ﹤0.01% 2047
2021
Q1 		$146K Sell
407
-10
-2% -$4.42K 0.01% 1533
2020
Q4 		$205K Buy
+417
New +$192K 0.01% 1440
2019
Q2 		– Sell
-254
Closed -$252K – 1799
2019
Q1 		$252K Buy
254
+10
+4% +$9.29K 0.01% 1370
2018
Q4 		$212K Buy
+244
New +$227K 0.01% 1380
2018
Q3 		– Sell
-248
Closed -$228K – 1458
2018
Q2 		$228K Buy
+248
New +$266K 0.01% 1488

Other funds holding ATRA

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Centiva Capital New York $11.5B AUM 31.97% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Amalgamated Bank's ATRA Position: Q2 2024 in Review

Amalgamated Bank sold out of Atara Biotherapeutics (ATRA) in Q2 2024, closing a stake of 129 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in ATRA in Q2 2018 and held it in 17 quarters. The position peaked at $252K in Q1 2019. 48 funds tracked by Wall St. Rank hold ATRA as of Q2 2024.

  • Amalgamated Bank reported no remaining Atara Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 129 Atara Biotherapeutics shares in Q2 2024, an estimated $2K.
  • Amalgamated Bank first reported a position in Atara Biotherapeutics in Q2 2018 and held it in 17 quarters.
  • Amalgamated Bank's Atara Biotherapeutics position peaked at $252K in Q1 2019.
  • 48 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.